DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Chlorpromazine hydrochlorideis the generic ingredient in five branded drugs marketed by Glaxosmithkline, Actavis Mid Atlantic, Pharm Assoc, Wockhardt, Hikma, Fosun Pharma, Abraxis Pharm, Dr Reddys, Marsam Pharms Llc, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Abbott, Amneal Pharms Co, Cycle Pharms Ltd, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Purepac Pharm, Pvt Form, Sandoz, Upsher Smith Labs, Vangard, West Ward, Zydus, and Parke Davis, and is included in sixty-five NDAs. Additional information is available in the individual branded drug profile pages.
There are twenty-four drug master file entries for chlorpromazine hydrochloride. Fifteen suppliers are listed for this compound.
Summary for chlorpromazine hydrochloride
Recent Clinical Trials for chlorpromazine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|Cairo University||Phase 1/Phase 2|
|Centre Hospitalier St Anne||Phase 3|
|Hôpital Cochin||Phase 3|
Pharmacology for chlorpromazine hydrochloride
|Drug Class||Phenothiazine |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Fosun Pharma||SONAZINE||chlorpromazine hydrochloride||SYRUP;ORAL||083040-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Parke Davis||PROMAPAR||chlorpromazine hydrochloride||TABLET;ORAL||084423-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Upsher Smith Labs||CHLORPROMAZINE HYDROCHLORIDE||chlorpromazine hydrochloride||TABLET;ORAL||084114-001||Approved Prior to Jan 1, 1982||AB||RX||No||Yes||Start Trial||Start Trial||Start Trial|
|Wockhardt||CHLORPROMAZINE HYDROCHLORIDE||chlorpromazine hydrochloride||CONCENTRATE;ORAL||087032-001||Jul 8, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|West Ward||CHLORPROMAZINE HYDROCHLORIDE||chlorpromazine hydrochloride||TABLET;ORAL||087783-001||Sep 16, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.